Publications by authors named "Elizabeth L Deane"
Article Synopsis
- Patients with end-stage ankle osteoarthritis face limited mobility and have two main surgical options: total ankle replacement (TAR) and ankle fusion (AF).
- The study aimed to compare the costs and quality of life improvements associated with TAR versus AF over 52 weeks and over the patients' lifetime, using a cost-utility analysis on 282 participants from a trial.
- Results showed TAR was more expensive than AF at 52 weeks, with a cost-effectiveness ratio indicating TAR isn't cost-effective in the short term; however, long-term modeling suggested it could become cost-effective, with a 69% likelihood if using a threshold of £20,000 per quality-adjusted life-year gained.
Background: We aimed to compare the clinical effectiveness, cost-effectiveness and complication rates of total ankle replacement with those of arthrodesis (i.e. ankle fusion) in the treatment of end-stage ankle osteoarthritis.
View Article and Find Full Text PDFBackground: End-stage ankle osteoarthritis causes severe pain and disability. There are no randomized trials comparing the 2 main surgical treatments: total ankle replacement (TAR) and ankle fusion (AF).
Objective: To determine which treatment is superior in terms of clinical scores and adverse events.